2018-2023 Global Influenza Vaccines Consumption Market Report

2018-2023 Global Influenza Vaccines Consumption Market Report

Category

Pharmaceuticals

Published Date

23rd Sep 2018

Pages

162

Choose License

Final Price

This report covers the present scenario (with the base year being 2017) and the growth prospects of global Influenza Vaccines market for 2018-2023.

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The CDC estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. When an immunized worker does catch the flu, they are on average back at work a half day sooner. Vaccine effectiveness in those under two years old and over 65 years old remains unknown due to the low quality of the research. needs update][8][needs update] Vaccinating children may protect those around them.

The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) recommend yearly vaccination for nearly all people over the age of six months, especially those at high risk. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.

The vaccines are generally safe. Fever occurs in five to ten percent of children vaccinated. Temporary muscle pains or feelings of tiredness may occur as well. In certain years, the vaccine has been linked to an increase in Guillain–Barré syndrome among older people at a rate of about one case per million doses. It should not be given to those with severe allergies to eggs or to previous versions of the vaccine. The vaccines come in both inactive and weakened viral forms. The inactive version should be used for those who are pregnant. They come in forms that are injected into a muscle, sprayed into the nose, or injected into the middle layer of the skin.

Vaccination against influenza began in the 1930s with large scale availability in the United States beginning in 1945. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale price in the developing world is about $5.25 USD per dose as of 2014.In the United States, it costs less than $25 USD as of 2015.

Over the next five years, this report projects that Influenza Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccines market by product type, application, key manufacturers and key regions.

To calculate the market size, this report considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Trivalent Flu Vaccines
Quadrivalent Flu Vaccines
Segmentation by application:
Adults
Pediatrics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitech
Vaxart
Vaxine Pty
Visterra

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Influenza Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Influenza Vaccines market by identifying its various subsegments.
Focuses on the key global Influenza Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Influenza Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Influenza Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2018-2023 Global Influenza Vaccines Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Vaccines Consumption 2013-2023
2.1.2 Influenza Vaccines Consumption CAGR by Region
2.2 Influenza Vaccines Segment by Type
2.2.1 Trivalent Flu Vaccines
2.2.2 Quadrivalent Flu Vaccines
2.3 Influenza Vaccines Consumption by Type
2.3.1 Global Influenza Vaccines Consumption Market Share by Type (2013-2018)
2.3.2 Global Influenza Vaccines Revenue and Market Share by Type (2013-2018)
2.3.3 Global Influenza Vaccines Sale Price by Type (2013-2018)
2.4 Influenza Vaccines Segment by Application
2.4.1 Adults
2.4.2 Pediatrics
2.5 Influenza Vaccines Consumption by Application
2.5.1 Global Influenza Vaccines Consumption Market Share by Application (2013-2018)
2.5.2 Global Influenza Vaccines Value and Market Share by Application (2013-2018)
2.5.3 Global Influenza Vaccines Sale Price by Application (2013-2018)

3 Global Influenza Vaccines by Players
3.1 Global Influenza Vaccines Sales Market Share by Players
3.1.1 Global Influenza Vaccines Sales by Players (2016-2018)
3.1.2 Global Influenza Vaccines Sales Market Share by Players (2016-2018)
3.2 Global Influenza Vaccines Revenue Market Share by Players
3.2.1 Global Influenza Vaccines Revenue by Players (2016-2018)
3.2.2 Global Influenza Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global Influenza Vaccines Sale Price by Players
3.4 Global Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Influenza Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Influenza Vaccines by Regions
4.1 Influenza Vaccines by Regions
4.1.1 Global Influenza Vaccines Consumption by Regions
4.1.2 Global Influenza Vaccines Value by Regions
4.2 Americas Influenza Vaccines Consumption Growth
4.3 APAC Influenza Vaccines Consumption Growth
4.4 Europe Influenza Vaccines Consumption Growth
4.5 Middle East & Africa Influenza Vaccines Consumption Growth

5 Americas
5.1 Americas Influenza Vaccines Consumption by Countries
5.1.1 Americas Influenza Vaccines Consumption by Countries (2013-2018)
5.1.2 Americas Influenza Vaccines Value by Countries (2013-2018)
5.2 Americas Influenza Vaccines Consumption by Type
5.3 Americas Influenza Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Influenza Vaccines Consumption by Countries
6.1.1 APAC Influenza Vaccines Consumption by Countries (2013-2018)
6.1.2 APAC Influenza Vaccines Value by Countries (2013-2018)
6.2 APAC Influenza Vaccines Consumption by Type
6.3 APAC Influenza Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Influenza Vaccines by Countries
7.1.1 Europe Influenza Vaccines Consumption by Countries (2013-2018)
7.1.2 Europe Influenza Vaccines Value by Countries (2013-2018)
7.2 Europe Influenza Vaccines Consumption by Type
7.3 Europe Influenza Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Influenza Vaccines by Countries
8.1.1 Middle East & Africa Influenza Vaccines Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Influenza Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa Influenza Vaccines Consumption by Type
8.3 Middle East & Africa Influenza Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Influenza Vaccines Distributors
10.3 Influenza Vaccines Customer

11 Global Influenza Vaccines Market Forecast
11.1 Global Influenza Vaccines Consumption Forecast (2018-2023)
11.2 Global Influenza Vaccines Forecast by Regions
11.2.1 Global Influenza Vaccines Forecast by Regions (2018-2023)
11.2.2 Global Influenza Vaccines Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Vaccines Forecast by Type
11.8 Global Influenza Vaccines Forecast by Application

12 Key Players Analysis
12.1 AstraZeneca
12.1.1 Company Details
12.1.2 Influenza Vaccines Product Offered
12.1.3 AstraZeneca Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 AstraZeneca News
12.2 CSL
12.2.1 Company Details
12.2.2 Influenza Vaccines Product Offered
12.2.3 CSL Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 CSL News
12.3 GlaxoSmithKline
12.3.1 Company Details
12.3.2 Influenza Vaccines Product Offered
12.3.3 GlaxoSmithKline Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 GlaxoSmithKline News
12.4 Sanofi
12.4.1 Company Details
12.4.2 Influenza Vaccines Product Offered
12.4.3 Sanofi Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sanofi News
12.5 Altimmune
12.5.1 Company Details
12.5.2 Influenza Vaccines Product Offered
12.5.3 Altimmune Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Altimmune News
12.6 BionVax
12.6.1 Company Details
12.6.2 Influenza Vaccines Product Offered
12.6.3 BionVax Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 BionVax News
12.7 FluGen
12.7.1 Company Details
12.7.2 Influenza Vaccines Product Offered
12.7.3 FluGen Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 FluGen News
12.8 FOLIA BIOTECH
12.8.1 Company Details
12.8.2 Influenza Vaccines Product Offered
12.8.3 FOLIA BIOTECH Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 FOLIA BIOTECH News
12.9 Genentech
12.9.1 Company Details
12.9.2 Influenza Vaccines Product Offered
12.9.3 Genentech Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Genentech News
12.10 Green Cross
12.10.1 Company Details
12.10.2 Influenza Vaccines Product Offered
12.10.3 Green Cross Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Green Cross News
12.11 Medicago
12.12 Moderna Therapeutics
12.13 Novavax
12.14 Shijiazhuang Yiling Pharmaceutical
12.15 SK Chemicals
12.16 UNM Pharma
12.17 Vaccitech
12.18 Vaxart
12.19 Vaxine Pty
12.20 Visterra

13 Research Findings and Conclusion
List of Tables and Figures_x000D_
_x000D_
Figure Picture of Influenza Vaccines_x000D_
Table Product Specifications of Influenza Vaccines_x000D_
Figure Influenza Vaccines Report Years Considered_x000D_
Figure Market Research Methodology_x000D_
Figure Global Influenza Vaccines Consumption Growth Rate 2013-2023 (K Units)_x000D_
Figure Global Influenza Vaccines Value Growth Rate 2013-2023 ($ Millions)_x000D_
Table Influenza Vaccines Consumption CAGR by Region 2013-2023 ($ Millions)_x000D_
Figure Product Picture of Trivalent Flu Vaccines_x000D_
Table Major Players of Trivalent Flu Vaccines_x000D_
Figure Product Picture of Quadrivalent Flu Vaccines_x000D_
Table Major Players of Quadrivalent Flu Vaccines_x000D_
Table Global Consumption Sales by Type (2013-2018)_x000D_
Table Global Influenza Vaccines Consumption Market Share by Type (2013-2018)_x000D_
Figure Global Influenza Vaccines Consumption Market Share by Type (2013-2018)_x000D_
Table Global Influenza Vaccines Revenue by Type (2013-2018) ($ million)_x000D_
Table Global Influenza Vaccines Value Market Share by Type (2013-2018) ($ Millions)_x000D_
Figure Global Influenza Vaccines Value Market Share by Type (2013-2018)_x000D_
Table Global Influenza Vaccines Sale Price by Type (2013-2018)_x000D_
Figure Influenza Vaccines Consumed in Adults_x000D_
Figure Global Influenza Vaccines Market: Adults (2013-2018) (K Units)_x000D_
Figure Global Influenza Vaccines Market: Adults (2013-2018) ($ Millions)_x000D_
Figure Global Adults YoY Growth ($ Millions)_x000D_
Figure Influenza Vaccines Consumed in Pediatrics_x000D_
Figure Global Influenza Vaccines Market: Pediatrics (2013-2018) (K Units)_x000D_
Figure Global Influenza Vaccines Market: Pediatrics (2013-2018) ($ Millions)_x000D_
Figure Global Pediatrics YoY Growth ($ Millions)_x000D_
Table Global Consumption Sales by Application (2013-2018)_x000D_
Table Global Influenza Vaccines Consumption Market Share by Application (2013-2018)_x000D_
Figure Global Influenza Vaccines Consumption Market Share by Application (2013-2018)_x000D_
Table Global Influenza Vaccines Value by Application (2013-2018)_x000D_
Table Global Influenza Vaccines Value Market Share by Application (2013-2018)_x000D_
Figure Global Influenza Vaccines Value Market Share by Application (2013-2018)_x000D_
Table Global Influenza Vaccines Sale Price by Application (2013-2018)_x000D_
Table Global Influenza Vaccines Sales by Players (2016-2018) (K Units)_x000D_
Table Global Influenza Vaccines Sales Market Share by Players (2016-2018)_x000D_
Figure Global Influenza Vaccines Sales Market Share by Players in 2016_x000D_
Figure Global Influenza Vaccines Sales Market Share by Players in 2017_x000D_
Table Global Influenza Vaccines Revenue by Players (2016-2018) ($ Millions)_x000D_
Table Global Influenza Vaccines Revenue Market Share by Players (2016-2018)_x000D_
Figure Global Influenza Vaccines Revenue Market Share by Players in 2016_x000D_
Figure Global Influenza Vaccines Revenue Market Share by Players in 2017_x000D_
Table Global Influenza Vaccines Sale Price by Players (2016-2018)_x000D_
Figure Global Influenza Vaccines Sale Price by Players in 2017_x000D_
Table Global Influenza Vaccines Manufacturing Base Distribution and Sales Area by Players_x000D_
Table Players Influenza Vaccines Products Offered_x000D_
Table Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) (2016-2018)_x000D_
Table Global Influenza Vaccines Consumption by Regions 2013-2018 (K Units)_x000D_
Table Global Influenza Vaccines Consumption Market Share by Regions 2013-2018_x000D_
Figure Global Influenza Vaccines Consumption Market Share by Regions 2013-2018_x000D_
Table Global Influenza Vaccines Value by Regions 2013-2018 ($ Millions)_x000D_
Table Global Influenza Vaccines Value Market Share by Regions 2013-2018_x000D_
Figure Global Influenza Vaccines Value Market Share by Regions 2013-2018_x000D_
Figure Americas Influenza Vaccines Consumption 2013-2018 (K Units)_x000D_
Figure Americas Influenza Vaccines Value 2013-2018 ($ Millions)_x000D_
Figure APAC Influenza Vaccines Consumption 2013-2018 (K Units)_x000D_
Figure APAC Influenza Vaccines Value 2013-2018 ($ Millions)_x000D_
Figure Europe Influenza Vaccines Consumption 2013-2018 (K Units)_x000D_
Figure Europe Influenza Vaccines Value 2013-2018 ($ Millions)_x000D_
Figure Middle East & Africa Influenza Vaccines Consumption 2013-2018 (K Units)_x000D_
Figure Middle East & Africa Influenza Vaccines Value 2013-2018 ($ Millions)_x000D_
Table Americas Influenza Vaccines Consumption by Countries (2013-2018) (K Units)_x000D_
Table Americas Influenza Vaccines Consumption Market Share by Countries (2013-2018)_x000D_
Figure Americas Influenza Vaccines Consumption Market Share by Countries in 2017_x000D_
Table Americas Influenza Vaccines Value by Countries (2013-2018) ($ Millions)_x000D_
Table Americas Influenza Vaccines Value Market Share by Countries (2013-2018)_x000D_
Figure Americas Influenza Vaccines Value Market Share by Countries in 2017_x000D_
Table Americas Influenza Vaccines Consumption by Type (2013-2018) (K Units)_x000D_
Table Americas Influenza Vaccines Consumption Market Share by Type (2013-2018)_x000D_
Figure Americas Influenza Vaccines Consumption Market Share by Type in 2017_x000D_
Table Americas Influenza Vaccines Consumption by Application (2013-2018) (K Units)_x000D_
Table Americas Influenza Vaccines Consumption Market Share by Application (2013-2018)_x000D_
Figure Americas Influenza Vaccines Consumption Market Share by Application in 2017_x000D_
Figure United States Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure United States Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Canada Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Canada Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Mexico Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Mexico Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Table APAC Influenza Vaccines Consumption by Countries (2013-2018) (K Units)_x000D_
Table APAC Influenza Vaccines Consumption Market Share by Countries (2013-2018)_x000D_
Figure APAC Influenza Vaccines Consumption Market Share by Countries in 2017_x000D_
Table APAC Influenza Vaccines Value by Countries (2013-2018) ($ Millions)_x000D_
Table APAC Influenza Vaccines Value Market Share by Countries (2013-2018)_x000D_
Figure APAC Influenza Vaccines Value Market Share by Countries in 2017_x000D_
Table APAC Influenza Vaccines Consumption by Type (2013-2018) (K Units)_x000D_
Table APAC Influenza Vaccines Consumption Market Share by Type (2013-2018)_x000D_
Figure APAC Influenza Vaccines Consumption Market Share by Type in 2017_x000D_
Table APAC Influenza Vaccines Consumption by Application (2013-2018) (K Units)_x000D_
Table APAC Influenza Vaccines Consumption Market Share by Application (2013-2018)_x000D_
Figure APAC Influenza Vaccines Consumption Market Share by Application in 2017_x000D_
Figure China Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure China Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Japan Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Japan Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Korea Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Korea Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Southeast Asia Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Southeast Asia Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure India Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure India Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Australia Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Australia Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Table Europe Influenza Vaccines Consumption by Countries (2013-2018) (K Units)_x000D_
Table Europe Influenza Vaccines Consumption Market Share by Countries (2013-2018)_x000D_
Figure Europe Influenza Vaccines Consumption Market Share by Countries in 2017_x000D_
Table Europe Influenza Vaccines Value by Countries (2013-2018) ($ Millions)_x000D_
Table Europe Influenza Vaccines Value Market Share by Countries (2013-2018)_x000D_
Figure Europe Influenza Vaccines Value Market Share by Countries in 2017_x000D_
Table Europe Influenza Vaccines Consumption by Type (2013-2018) (K Units)_x000D_
Table Europe Influenza Vaccines Consumption Market Share by Type (2013-2018)_x000D_
Figure Europe Influenza Vaccines Consumption Market Share by Type in 2017_x000D_
Table Europe Influenza Vaccines Consumption by Application (2013-2018) (K Units)_x000D_
Table Europe Influenza Vaccines Consumption Market Share by Application (2013-2018)_x000D_
Figure Europe Influenza Vaccines Consumption Market Share by Application in 2017_x000D_
Figure Germany Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Germany Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure France Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure France Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure UK Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure UK Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Italy Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Italy Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Russia Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Russia Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Spain Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Spain Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Table Middle East & Africa Influenza Vaccines Consumption by Countries (2013-2018) (K Units)_x000D_
Table Middle East & Africa Influenza Vaccines Consumption Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Influenza Vaccines Consumption Market Share by Countries in 2017_x000D_
Table Middle East & Africa Influenza Vaccines Value by Countries (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa Influenza Vaccines Value Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Influenza Vaccines Value Market Share by Countries in 2017_x000D_
Table Middle East & Africa Influenza Vaccines Consumption by Type (2013-2018) (K Units)_x000D_
Table Middle East & Africa Influenza Vaccines Consumption Market Share by Type (2013-2018)_x000D_
Figure Middle East & Africa Influenza Vaccines Consumption Market Share by Type in 2017_x000D_
Table Middle East & Africa Influenza Vaccines Consumption by Application (2013-2018) (K Units)_x000D_
Table Middle East & Africa Influenza Vaccines Consumption Market Share by Application (2013-2018)_x000D_
Figure Middle East & Africa Influenza Vaccines Consumption Market Share by Application in 2017_x000D_
Figure Egypt Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Egypt Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure South Africa Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure South Africa Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Israel Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Israel Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure Turkey Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure Turkey Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Figure GCC Countries Influenza Vaccines Consumption Growth 2013-2018 (K Units)_x000D_
Figure GCC Countries Influenza Vaccines Value Growth 2013-2018 ($ Millions)_x000D_
Table Influenza Vaccines Distributors List_x000D_
Table Influenza Vaccines Customer List_x000D_
Figure Global Influenza Vaccines Consumption Growth Rate Forecast (2018-2023) (K Units)_x000D_
Figure Global Influenza Vaccines Value Growth Rate Forecast (2018-2023) ($ Millions)_x000D_
Table Global Influenza Vaccines Consumption Forecast by Countries (2018-2023) (K Units)_x000D_
Table Global Influenza Vaccines Consumption Market Forecast by Regions_x000D_
Table Global Influenza Vaccines Value Forecast by Countries (2018-2023) ($ Millions)_x000D_
Table Global Influenza Vaccines Value Market Share Forecast by Regions_x000D_
Figure Americas Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Americas Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure APAC Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure APAC Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Europe Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Europe Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Middle East & Africa Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Middle East & Africa Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure United States Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure United States Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Canada Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Canada Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Mexico Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Mexico Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Brazil Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Brazil Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure China Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure China Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Japan Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Japan Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Korea Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Korea Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Southeast Asia Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Southeast Asia Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure India Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure India Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Australia Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Australia Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Germany Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Germany Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure France Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure France Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure UK Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure UK Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Italy Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Italy Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Russia Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Russia Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Spain Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Spain Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Egypt Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Egypt Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure South Africa Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure South Africa Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Israel Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Israel Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure Turkey Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure Turkey Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Figure GCC Countries Influenza Vaccines Consumption 2018-2023 (K Units)_x000D_
Figure GCC Countries Influenza Vaccines Value 2018-2023 ($ Millions)_x000D_
Table Global Influenza Vaccines Consumption Forecast by Type (2018-2023) (K Units)_x000D_
Table Global Influenza Vaccines Consumption Market Share Forecast by Type (2018-2023)_x000D_
Table Global Influenza Vaccines Value Forecast by Type (2018-2023) ($ Millions)_x000D_
Table Global Influenza Vaccines Value Market Share Forecast by Type (2018-2023)_x000D_
Table Global Influenza Vaccines Consumption Forecast by Application (2018-2023) (K Units)_x000D_
Table Global Influenza Vaccines Consumption Market Share Forecast by Application (2018-2023)_x000D_
Table Global Influenza Vaccines Value Forecast by Application (2018-2023) ($ Millions)_x000D_
Table Global Influenza Vaccines Value Market Share Forecast by Application (2018-2023)_x000D_
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table AstraZeneca Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure AstraZeneca Influenza Vaccines Market Share (2016-2018)_x000D_
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table CSL Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure CSL Influenza Vaccines Market Share (2016-2018)_x000D_
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table GlaxoSmithKline Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure GlaxoSmithKline Influenza Vaccines Market Share (2016-2018)_x000D_
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Sanofi Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Sanofi Influenza Vaccines Market Share (2016-2018)_x000D_
Table Altimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Altimmune Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Altimmune Influenza Vaccines Market Share (2016-2018)_x000D_
Table BionVax Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table BionVax Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure BionVax Influenza Vaccines Market Share (2016-2018)_x000D_
Table FluGen Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table FluGen Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure FluGen Influenza Vaccines Market Share (2016-2018)_x000D_
Table FOLIA BIOTECH Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table FOLIA BIOTECH Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure FOLIA BIOTECH Influenza Vaccines Market Share (2016-2018)_x000D_
Table Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Genentech Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Genentech Influenza Vaccines Market Share (2016-2018)_x000D_
Table Green Cross Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Green Cross Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Green Cross Influenza Vaccines Market Share (2016-2018)_x000D_
Table Medicago Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Moderna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Shijiazhuang Yiling Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table SK Chemicals Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table UNM Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Vaccitech Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Vaxart Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Vaxine Pty Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Visterra Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us